The dual pathogenesis of paroxysmal nocturnal hemoglobinuria

Current Opinion in Hematology

Volumn 3, Issue 2, 1996, Pages 101-110

  Luzzatto, Lucio ^a   Bessler, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; GLYCOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN;

APLASTIC ANEMIA; BONE MARROW DEPRESSION; CLONOGENESIS; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HYBRID CELL; MOLECULAR CLONING; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; X CHROMOSOME LINKAGE;

EID: 0029887115     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603020-00001     Document Type: Review

References (70)

1. Marchiafava E, Nazari A: Nuovo contributo allo studio degli itteri cronici emolitici. Policlinico (Sezione Medica) 1911, 18:241-254.
2. Ham T: Chronic haemolytic anaemia with paroxysmal nocturnal hemoglobinuria: study of the mechanism of haemolysis in relation to acid-base equilibrium. N Engl J Med 1937, 217:915-918.
3. Dacie JV, Israëls MCG, Wilkinson JF: Paroxysmal nocturnal hemoglobinuria of the Marchiafava type. Lancet 1938, 1:479-491.
4. Voswinkler P: Der schwarze Urin. Berlin Blackwell 1993:1-282.
5. Strübing P: Paroxysmale Hämoglobinurie. Dtsch Med Wochenschr 1882, 8:1-3, 18-21.
6. Hijmans van den Bergh A: Ictère hémolytique avec crises hémoglobin-uriques. Rev Méd 1911, 31:63-69.
7. Hillmen P, Lewis MS, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995, 333:1253-1258. This long-term follow-up of 80 patients with PNH showed a median survival of 10 years. The most frequent life-threatening complication of the disease was venous thrombosis. Spontaneous long-term clinical recovery can occur in some patients, with complete disappearance of PNH erythrocytes and PNH neutrophils. However, the persistence of PNH lymphocytes in this situation indicates that the PNH clone still persists but has apparently lost its growth advantage.
8. Kinoshita T, Inoue N, Takeda J: Defective glycosyl phosphatidylinositol (GPI)-anchor synthesis and paroxysmal nocturnal hemoglobinuria. Adv Immunol 1995, 60:57-103. A comprehensive review of GPI-anchored proteins and of the defects that may occur in the GPI anchors' biosynthesis in relation to PNH.
9. Rosse W, Ware RE: The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995, 86:3277-3286. A comprehensive review of the PIG-A mutations observed in PNH.
10. Rosse WF: Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 1990, 75:1595-1601.
11. Rotoli B, Bessler M, Alfinito F, del Vecchio L: Membrane proteins in paroxysmal nocturnal hemoglobinuria. Blood Rev 1993, 7:75-86.
12. Rotoli B, Luzzatto L: Paroxysmal nocturnal hemoglobinuria. Bailliere's Clin Haematol 1989, 2:113-138.
13. Rosse WF, Dacie JV: Immune lysis of normal human and paroxysmal nocturnal haemoglobinuria (PNH) red blood cells: I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 1966, 45:736-748.
14. Oni SB, Osunkoya BO, Luzzatto L: Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 1970, 36:145-152.
15. Bessler M, Mason PJ, Hillmen P, Luzzatto L: Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 1994, 343:951-953. The first demonstration of the finding of more than one PNH clone in PNH patients. This finding strongly supports the hypothesis of a relative selective growth advantage and suggests that PIG-A mutations are nature's chosen escape from the mechanism causing bone marrow failure.
16. Ostendorf T, Nishan C, Schubert J, Grussenmeyer T, Scholz C, Zielinka-Showronek M, Schmidt R: Heterogeneous PIG-A mutations in different cell lineages In paroxysmal nocturnal hemoglobinuria. Blood 1995, 85:1640-1646.
17. Yamada N, Miyata T, Maeda K, Kitani T, Takeda J, Kinoshita T: Somatic mutations in the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995, 85:885-892.
18. Pramoonjago P, Wanachiwanawin W, Chinprasertsak S, Pattanapanyasat K, Takeda J, Kinoshita T: Somatic mutation of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood 1995, 86:1736-1739.
19. Josten KM, Tooze JA, Borthwick-Clarke C, Gordon-Smith EC, Rutherford TR: Acquired aplastic anaemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood 1991, 78:3162-3167.
20. van Kamp H, Landegent JE, Jansen RPM, Willemze R, Fibbe WE: Clonal hematopoiesis in patient with acquired aplastic anaemia. Blood 1991, 78:3209-3214.
21. Luzzatto L: Leukemia is a genetic disorder of somatic cells. Hematologica 1990, 75:105-108.
22. Rotoli B, Boccuni P: The PIG-A gene somatic mutation responsible for paroxysmal nocturnal hemoglobinuria. Haematologica 1995, 80:544-550.
23. Kinoshita T, Medof ME, Silber R, Nussenzweig V: Distribution of decay accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal haemoglobinuria. J Exp Med 1985, 162:75-92.
24. Van der Schoot C, Huizinga T, Van't Veer-Karthof E, RW, JP, Van der Borne A: Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 1990, 76:1853-1859.
25. Kwong Y, Lee C, Chan T, Chan L: Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria. Am J Pathol 1994, 102:30-35.
26. Ueda E, Nishimura J-I, Kitani T, Nasu K, Kageyama T, Kim YU, Takeda J, Kinoshita T: Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines from patients with paroxysmal nocturnal haemoglobinuria. Int Immunol 1992, 4:1263-1271.
27. Hillmen P, Bessler M, Crawford DH, Luzzatto L: Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype. Blood 1993, 81:193-199.
28. Nakakuma H, Nagakura S, Horikawa K, Hidaka M, Kawaguchi T, Iwamoto N, Sanada I, Kagimoto T, Takatsuki K: Interleukin-2 dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria. Blood 1994, 84:309-314.
29. Schubert J, Uciechowski P, Delani P, Tischler H-J, Kolanus W, Schmidt R: The PIG-anchoring defect in NK lymphocytes of PNH patients. Blood 1990, 76:1181-1187.
30. Armstrong C, Schubert J, Ueda E, Knez JJ, Gelperin D, Hirose S, Silber R, Hollan S, Schmidt RE, Medof ME: Affected paroxysmal nocturnal haemoglobinuria T lymphocytes harbour a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1 -murine lymphoma mutants. J Biol Chem 1992, 267:25347-25351.
31. Takahashi M, Takeda J, Hirose S, Hyman R, Inoue N, Miyata T, Ueda E, Kitani T, Medof ME, Kinoshita T: Deficient biosynthesis of N-acetytglucosaminylphosphatidylinositol, an early intermediate of GPI anchor biosynthesis in cell lines established from patients with paroxysmal nocturnal hemoglobinuria J Exp Med 1993, 177:517-521.
32. Hillmen P, Bessler M, Mason P, Watkins W, Luzzatto L: Specific defect in N-acetylglucosamine incorporation in the GPI anchor synthetic pathway in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 1993, 90:5272-5276.
33. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahahi M, Kitani T, Kinoshita T: Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993, 73:703-711.
34. Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda J, Luzzatto L, Kinoshita T: Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 1994, 13:110-117. Demonstration that transfection with the PIG-A cDNA restores the expression of GPI-linked proteins on the surface of GH anchor-deficient lymphoblastoid cell lines obtained from patients with PNH. First description of three different PIG-A transcripts arising through alternative splicing.
35. Hillmen P, Bessler M, Bungey J, Luzzatto L: Paroxysmal nocturnal hemoglobinuria: correction of the abnormal phenotype by somatic cell hybridisation. Somat Cell Mol Genet 1993, 19:123-129.
36. Ware RE, Howard TA, Kamitani T, Chang HM, Yeh ETH, Seldin MF: Chromosomal assignment of genes involved in glycosylphosphatidylinositol anchor biosynthesis: implication for the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 1994, 83:3753-3757.
37. Kamitani T, Chang H-M, Rollins C, Waneck GL, Yeh ETH: Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk-cells by a human cDNA clone. J Biol Chem 1993, 268:20733-20736.
38. Davitz MA, Low MG, Nussenzweig V: Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). J Exp Med 1986, 163:1150-1161.
39. Low MG, Ferguson MAJ, Futerman AH, Silman I: Covalent attached phosphoinositol as a hydrophobic anchor for membrane proteins. Trends Biochem Sci 1986, 11:212-215.
40. Ferguson MAJ, Duszenko M, Lamont GS, Overath P, Cross GAM: Biosynthesis of Trypanosoma brucei variant surface glycoproteins. J Biol Chem 1986, 261:356-362.
41. Vidugiriene J, Menon AK: Early lipid intermediates in glycosyl-phosphatidylinositol anchor assembly are synthesized in the ER and located in the cytoplasmic leaflet of ER bilayer. J Cell Biol 1993, 121:987-996.
42. Vidugiriene J, Menon AK: The GPI-anchor of cell surface proteins is synthesized on the cytoplasmatic face of the endoplasmatic reticulum. J Cell Biol 1994, 127:333-341.
43. Vidugiriene J, Menon A: Biosynthesis of glycosylphosphatidylinositol anchors. In Methods in Enzymology, vol 250. Edited by Casey PJ, Buss JE. New York: Academic Press; 1995:513-535.
44. Hyman R: Somatic genetic analysis of the expression of cell surface molecules. Trends Genet 1988, 4:5-8.
45. Hirose S, Mohney RP, Mutka SC, Ravi L, Singelton DR, Perry G, Tartakoff AM, Medof ME: Derivation and characterisation of glycoinositol-phospholipid anchor-defective human K562 cell clones. J Biol Chem 1992, 267:5272-5278.
46. Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H: CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of complement membrane attack complex on homologous cells. J Exp Med 1989, 170:637-654.
47. Holguin MH, Fredrick LR, Bernshaw NJ, Wilcox LA, Parker W: Isolation and characterzation of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes in paroxysmal nocturnal hemoglobinuria. J Clin Invest 1989, 84:7-17.
48. Sugita Y, Tobe T, Oda E: Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement. J Biochem (Tokyo) 1989, 106:555-557.
49. Men S, Morgan B, Davies A, Daniels R, Olavesen M, Waldmann H, Lachmann P: Human protectin (CD59) an 18000-20000 MW complement lysis restriction factor, inhibits C5b-8 catalysed insertion into lipid bilayers. Immunology 1990, 71:1-9.
50. Hadam MR: Cluster report: CD59. In Leukocyte Typing IV, edn 4. Edited by Knapp W, Doerken B, Gilks WR, Rieber EP, Schmidt RE, Borne HSAEGKvd. Oxford: Oxford University Press; 1989:720-722.
51. Okada N, Harada R, Okada H: Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kDa homologous restriction factor. Clin Exp Immunol 1990, 80:109-113.
52. Rother RP, Rollins SA, Mennone J, Chodera A, Fidel SA, Hillmen P, Squinto SP: Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B-cells confers resistance to human complement Blood 1994, 84:2604-2611.
53. Yamashina M, Ueda E, Kinoshita T, Takami T, Ojima A, Ono H, Tanka H, Kondo N, Orii T, Okada N, Okada H, Inoue K, Kitani T: Inherited complement deficiency of 20 kilodalton homologous restriction factor (CD 59) as a cause of paroxysmal nocturnal haemoglobinuria. N Engl J Med 1990, 323:1184-1189.
54. Motoyama N, Okada N, Yamashina M, Okada H: Paroxysmal nocturnal haemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur J Immunol 1992, 22:2669-2673.
55. Tate CG, Uchikawa MJA, Tanner PA, Judson SF, Parson SF, Mallinson G, Anstee DJ: Studies on the defect which causes absence of decay acceleration factor from the peripheral blood cells of an individual with the Inab phenotype. J Exp Med 1989, 261:489-493. Report of a patient with inherited decay acceleration factor deficiency.
56. Merry AH, Rawlinson M, Uchikawa M, DHA MR, SIM RB: Studies on the sensitivity to complement mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor). Br J Haematol 1989, 73:248-253.
57. Hillmen P, Hadzic D, OConnor SJM, Mowat A: Hepatic vein thrombosis in a patient with the Inab phenotype: is deficiency of DAF important in the development of thrombosis in PNH [abstract]? Blood 1995, 86(suppl 1):514a.
58. Kinoshita T: Biology of complement. Immunol Today 1991, 12:291-295.
59. Miyata T, Takeda J, Iida J, Yamada N, Inoue N, Takahashi M, Maeda K, Kitani T, Kinoshita T: The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993, 259:1318-1320. Cloning and characterization of the PIG-A cDNA.
60. Bessler M, Hillman P, Longo L, Luzzatto L, Mason PJ: Genomic organisation of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related pseudogene mapped to 12q21. Hum Mol Genet 1994, 3:751-757. Cloning and chromosomal localization of the human PIG-A gene and of a related pseudogene.
61. Iida Y, Takeda J, Miyata T, Inoue N, Nishimura J, Kitani T, Maeda K, Kinoshita T: Characterization of genomic PIG-A gene: a gene for glycosylphosphatidylinositol-anchor biosythesis and paroxysmal nocturnal hemoglobinuria. Blood 1994, 83:3126-3131. Cloning of the human PIG-A gene and functional analysis of the PIG-A promotor region.
62. Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, Kinoshita T: Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 1994, 330:249-255. Demonstration of the heterogeneity of PIG-A mutations in patients with PNH.
63. Bessler M, Mason PJ, Hillmen P, Luzzatto L: Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1994, 87:863-866.
64. Ware RE, Rosse WF, Howard TA: Mutations within the PIG-A gene in patients with paroxysmal nocturnal hemoglobinuria. Blood 1994, 83:2418-2422.
65. Nafa K, Mason P, Hillmen P, Luzzatto L, Bessler M: Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria (PNH) are mainly of the frameshift type. Blood 1995, 86:4650-5655.
66. Nafa K, Bessler M, Mason P, Castro-Malaspina H, Jhanwar S, Deeg J, Luzzatto L: The complex nature of somatic mutations in paroxysmal nocturnal hemoglobinuria [abstract]. Blood 1995, 86(suppl 1):967a.
67. Vulliamy T, Beutler E, Luzzatto L: Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene. Hum Mutat 1993, 2:159-167.
68. Griscelli-Bennaceur A, Gluckman E, Scrobohaci M, Jonveaus P, Vu T, Bazarbachi A, Carosella E, Sigaux F, Socie G: Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood 1995, 85:1354-1363.
69. Nagarahjan, S, Brodsky RA, Young NS, Medof ME: Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995, 85:4656-4661.
70. Azenishi Y, Nishimura J, Ueda E, Hirota T, Inoue N, Takeda J, Kanakura Y, Akaogi T, Machii T, Mizoguchi H, Knoshita T, Kitani T: Analysis of the PIG-A gene in the blood cells from patients with aplastic anemia [abstract]. Blood 1994, 84:11a.